Perovskite PbCoO synthesized at 12 GPa was found to have an unusual charge distribution of PbPbCoCoO with charge orderings in both the A and B sites of perovskite ABO. Comprehensive studies using density functional theory (DFT) calculation, electron diffraction (ED), synchrotron X-ray diffraction (SXRD), neutron powder diffraction (NPD), hard X-ray photoemission spectroscopy (HAXPES), soft X-ray absorption spectroscopy (XAS), and measurements of specific heat as well as magnetic and electrical properties provide evidence of lead ion and cobalt ion charge ordering leading to PbPbCoCoO quadruple perovskite structure. It is shown that the average valence distribution of PbCoO between PbCrO and PbNiO can be stabilized by tuning the energy levels of Pb 6s and transition metal 3d orbitals.

We demonstrate suppression of crack generation in GaN epitaxy on Si using cubic SiC as intermediate layers. Crack-free GaN with a thickness of 2μm was obtained. Epilayers of SiC (0–1μm), thin AlN (50nm), and GaN (1–3μm) were prepared on 3in. (111)Si substrates (GaN∕AlN∕SiC∕Si) by metalorganic vapor-phase epitaxy. Cracking of GaN is suppressed with thicker SiC (1μm), whereas cracks are generated in GaN without SiC and with thinner SiC (50nm). Transmission electron microscopy analysis revealed monocrystalline wurzite structure of GaN. Current-voltage measurements showed breakdown voltage exceeding 250V, indicating its potential for high voltage application.

Background COVID-19 has worse mortality than influenza in American and European studies, but evidence from the Western Pacific region is scarce. Methods Using a large-scale multicenter inpatient claims data in Japan, we identified individuals hospitalised with COVID-19 in 2020 or influenza in 2017–2020. We compared patient characteristics, supportive care, and in-hospital mortality, with multivariable logistic regression analyses for in-hospital mortality overall, by age group, and among patients with mechanical ventilation. Findings We identified 16,790 COVID-19 patients and 27,870 influenza patients, with the different age distribution (peak at 70–89 years in COVID-19 vs. bimodal peaks at 0–9 and 80–89 years in influenza). On admission, the use of mechanical ventilation was similar in both groups (1·4% vs. 1·4%) but higher in the COVID-19 group (3·3% vs. 2·5%; p<0·0001) during the entire hospitalisation. The crude in-hospital mortality was 5·1% (856/16,790) for COVID-19 and 2·8% (791/27,870) for influenza. Adjusted for potential confounders, the in-hospital mortality was higher for COVID-19 than for influenza (adjusted odds ratio [aOR] 1·83, 95% confidence interval [CI] 1·64–2·04). In age-stratified analyses, the aOR (95%CI) were 0·78 (0·56–1·08) and 2·05 (1·83–2·30) in patients aged 20–69 years and ≥70 years, respectively (p-for-interaction<0·0001). Among patients with mechanical ventilation, the aOR was 0·79 (0·59–1·05). Interpretation Patients hospitalised with COVID-19 in Japan were more likely to die than those with influenza. However, this was mainly driven by findings in older people, and there was no difference once mechanical ventilation was started. Funding Ministry of Health, Labour and Welfare of Japan (21AA2007).

The valence distribution and local structure of Bi 1−x Pb x NiO 3 (x ≤ 0.25) were investigated by comprehensive studies of Rietveld analysis of synchrotron X-ray diffraction (SXRD) data, X-ray absorption spectroscopy (XAS), hard X-ray photoemission spectroscopy (HAXPES), and pair distribution function (PDF) analysis of synchrotron X-ray total scattering data. Disproportionation of Bi ions into Bi 3+ and Bi 5+ was observed for all the samples, but it was a longranged one with distinct crystallographic sites in the P1̅ triclinic structure for x ≤ 0.15, while the ordering was short-ranged for x = 0.20 and 0.25. An intermetallic charge transfer between Bi 5+ and Ni 2+ , leading to large volume shrinkage, was observed for all the samples upon heating at ∼500 K.

Stress in the epitaxial films of GaN on Si is reduced by using SiC as intermediate layers. The crystalline films of cubic SiC (0–1μm), thin AlN (50nm), and GaN (1–3μm) were prepared on 3in. (1 1 1) Si substrates—stacked in the order of GaN∕AlN∕SiC∕Si—by metalorganic vapor-phase epitaxy. It is revealed by Raman spectroscopy that the tensile stress in GaN is reduced to half (reduction of about 300MPa) for GaN on Si with SiC intermediate layers compared with GaN on Si without SiC intermediate layers. Because of stress reduction, crack-free GaN on Si with a thickness of 2μm was obtained by using SiC intermediate layers. Cracking was minimized even on thicker GaN on Si (3μm thick) with SiC intermediate layers. The SiC intermediate layers are promising for the realization of nitride based electronic devices on Si.

No abstract

The growth process of semipolar GaN(10-12) on Si(001) offcut substrates with 3C-SiC buffer layers has been investigated. From XRD analysis, the difference in the crystal orientation between GaN(10-12) and 3C-SiC(001) has been found to be around 8˚ toward the [110] direction of the 3C-SiC templates. From TEM observations, a cubic-phase AlN seed layer is found to grow on 3C-SiC(001) templates, and the swift transition from the cubic phase to a hexagonal phase leads to the stable growth of hexagonal nitrides. Using 8˚-offcut Si substrates, it is possible to obtain a mirror-like surface of GaN(10-12) using an approximately 10-nm-thick AlN seed layer, which swiftly transitions from cubic AlN to hexagonal GaN.

Nafamostat mesylate may be effective against coronavirus disease 2019 (COVID-19). However, it is not known whether its use is associated with reduced in-hospital mortality in clinical practice. We conducted a retrospective observational study to evaluate the effect of nafamostat mesylate in patients with COVID-19 using the Medical Data Vision Co. Ltd. hospital-based database in Japan. We compared patients with COVID-19 who were (n = 121) and were not (n = 15,738) administered nafamostat mesylate within 2 days of admission between January and December 2020. We conducted a 1:4 propensity score matching with multiple imputations for smoking status and body mass index and combined the 20 imputed propensity score-matched datasets to obtain the adjusted odds ratio for in-hospital mortality. Crude in-hospital mortality was 13.2% (16/121) and 5.0% (790/15,738), respectively. In the propensity score-matched analysis with multiple imputations, the adjusted odds ratio (use vs. no use of nafamostat mesylate) for in-hospital mortality was 1.27 (95% confidence interval: 0.61–2.64; p = 0.52). Sensitivity analyses showed similar results. The results of this retrospective observational study did not support an association between nafamostat mesylate and improved in-hospital outcomes in patients with COVID-19, although further studies with larger sample sizes are warranted to assess the generalizability of our findings.